HansBiomed Yönetim
Yönetim kriter kontrolleri 0/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Guen Young Kim
İcra Kurulu Başkanı
n/a
Toplam tazminat
CEO maaş yüzdesi | n/a |
CEO görev süresi | 3.8yrs |
CEO sahipliği | n/a |
Yönetim ortalama görev süresi | Veri yok |
Yönetim Kurulu ortalama görev süresi | Veri yok |
Son yönetim güncellemeleri
Recent updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Oct 29Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth
Feb 29Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?
Apr 10Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.
Jan 30Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Dec 08Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?
Nov 20CEO
Guen Young Kim
3.8yrs
Görev süresi
Guen Young Kim serves as Chief Executive Officer of HansBiomed Corp. since January 2021.